The resistance of immune checkpoint inhibitors is mainly related to the following factors: severe depletion of T cells, tumor-specific CD8+T lymphocyte deficiency, Immunosuppression of tumor microenvironment, and immune deficiency in lymphocyte desert-type tumors [48]. This evidence concerns the gene CD8A and Thymic aplasia.